Najafi-Hajivar Saeedeh, Zakeri-Milani Parvin, Mohammadi Hamed, Niazi Mehri, Soleymani-Goloujeh Mehdi, Baradaran Behzad, Valizadeh Hadi
Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Medical Nanotechnology Department, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Gastrointestinal Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Biomed Pharmacother. 2016 Oct;83:1365-1378. doi: 10.1016/j.biopha.2016.08.060. Epub 2016 Aug 28.
Nanotechnology increasingly plays a significant role in modern medicine development. The clear benefits of using nanomaterials in various biomedical applications are often challenged by concerns about the lack of adequate data regarding their toxicity. Two decades of nanotoxicology research have shown that the interactions between nanoparticles (NPs) and biosystem are remarkably complex. This complexity derives from NPs' ability to bind and interact with biological cells and change their surface characteristics. One area of interest involves the interactions between NPs and the immune component. Immune system's function in the maintenance of tissue homeostasis is to protect the host from unfamiliar agents. This is done through effective surveillance and elimination of foreign substances and abnormal self cells from the body. Research shows that nanomaterials can stimulate and/or suppress the immune responses, and that their compatibility with the immune system is largely determined by their surface properties. NP size, shape, composition, protein binding and administration routes seem to be the main factors that contribute to the interactions of NPs with the immune system. In the present article, we focus on the relationship between effective physiochemical properties of NPs and their immunogenic effects. In addition, we review more details about immunological responses of different types of NPs. Understanding the interactions of nanomaterials with the immune system is essential for the engineering of new NP-based systems for medical applications.
纳米技术在现代医学发展中日益发挥着重要作用。在各种生物医学应用中使用纳米材料的明显益处,常常受到对其毒性缺乏足够数据的担忧的挑战。二十年的纳米毒理学研究表明,纳米颗粒(NPs)与生物系统之间的相互作用非常复杂。这种复杂性源于纳米颗粒与生物细胞结合和相互作用并改变其表面特性的能力。一个感兴趣的领域涉及纳米颗粒与免疫成分之间的相互作用。免疫系统在维持组织稳态中的功能是保护宿主免受外来病原体的侵害。这是通过对体内异物和异常自身细胞进行有效监测和清除来实现的。研究表明,纳米材料可以刺激和/或抑制免疫反应,并且它们与免疫系统的相容性很大程度上取决于其表面性质。纳米颗粒的大小、形状、组成、蛋白质结合和给药途径似乎是导致纳米颗粒与免疫系统相互作用的主要因素。在本文中,我们重点关注纳米颗粒有效的物理化学性质与其免疫原性效应之间的关系。此外,我们还回顾了有关不同类型纳米颗粒免疫反应的更多细节。了解纳米材料与免疫系统之间的相互作用对于设计用于医学应用的新型基于纳米颗粒的系统至关重要。
Biomed Pharmacother. 2016-10
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011-12-5
Semin Immunol. 2017-10-4
Toxicol Appl Pharmacol. 2016-5-15
Nanomedicine (Lond). 2015-7-2
Nat Nanotechnol. 2007-8
Int J Immunopathol Pharmacol. 2011
Endocrinology. 2009-12-16
Int Immunopharmacol. 2024-6-30
Int J Nanomedicine. 2014-12-18
Mater Today Bio. 2025-8-3